Trials / Completed
CompletedNCT03424707
A Study to Evaluate the Efficacy and Safety of Fixed Dose Combination of DW340 in Patients With Acute Low Back Pain
A Single-Center, Randomized, Double-Blind, Parallel, Pilot Study to Evaluate the Efficacy and Safety of Fixed Dose Combination of DW340 in Patients With Acute Low Back Pain
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 45 (actual)
- Sponsor
- Daewon Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
A Single-Center, Randomized, Double-Blind, Parallel, Pilot Study to Evaluate the Efficacy and Safety of Fixed Dose Combination of Pelubiprofen/Eperisone in Patients with Acute Low Back Pain
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DW340(pelubiprofen/eperisone) | DW340 |
| DRUG | Pelubi(pelubiprofen) | pelubiprofen |
| DRUG | Placebo Oral Tablet | Placebo Oral Tablet |
Timeline
- Start date
- 2016-03-04
- Primary completion
- 2016-08-30
- Completion
- 2016-08-30
- First posted
- 2018-02-07
- Last updated
- 2018-02-07
Source: ClinicalTrials.gov record NCT03424707. Inclusion in this directory is not an endorsement.